To identify whether the binding of PD-1 and PD-L1 could activate the intracellular signaling in tumor cells, we used an activated PD-1 polypeptide to stimulate TCL cell lines for 30 min to 2 h and tested downstream phosphorylated protein levels by western blotting. Here, PDCD1 is linked to neoplasm.